who we are
Servier is a privately held leader in oncology dedicated to bringing the promise of tomorrow to the patients we serve.
Launched by Servier Group, a unique global organization operating in more than 150 countries and governed by a non-profit foundation, Servier in the U.S. is a privately held Oncology leader and has the resources and network of an established global pharmaceutical company, while operating with the nimble and entrepreneurial spirit of biotech.
How We Lead
As a privately held Oncology leader, Servier is committed to finding solutions for patients living with difficult and hard-to-treat diseases. The company’s oncology portfolio consists of first-in-class and best-in-class medicines designed to bring transformative precision therapies to a greater number of patients.
Governed by a non-profit foundation, Servier approaches innovation with a long-term vision, free of influence from investors and outside pressure to chase short-term monetary targets. At Servier, we bring the patient voice into everything we do, and our commitment to patients extends far beyond approval.
At Servier, each person is propelled by a collective mission to serve those grappling with difficult and hard-to-treat diseases. Our values — daring to innovate, caring deeply, committing to success, and growing through shared efforts — not only guide our daily endeavors but also fuel our corporate responsibility initiatives.
Serving our community is at the heart of our commitment to making a meaningful impact on lives.
For more information on Servier Group’s commitment, download our Corporate Sustainability Report.